Palladone and Revlimid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Palladone (hydromorphone hydrochloride) and Revlimid (lenalidomide). Common drug interactions include cardiac failure among females and hypocalcaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Palladone and Revlimid. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Palladone?

Palladone has active ingredients of hydromorphone hydrochloride. eHealthMe is studying from 2,546 Palladone users. Check the latest studies of Palladone.

What is Revlimid?

Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. eHealthMe is studying from 378,026 Revlimid users. Check the latest studies of Revlimid.

On Jul, 14, 2026

32 people who take Palladone and Revlimid together, and have interactions are studied.

Palladone and Revlimid drug interactions.

What are the common drug interactions of Palladone and Revlimid, by gender? *:

female:

Cardiac failure
Gastrointestinal stromal tumour (a cancer that arises from transformed cells of mesenchymal origin in gastrointestinal tract)
Febrile neutropenia (fever with reduced white blood cells)
General physical health deterioration (weak health status)
Renal failure (kidney dysfunction)
Appetite disorder (abnormal eating habits)
Asthma
Cough
Drug ineffective
Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions)

male:

Hypocalcaemia (levels of calcium in blood serum are abnormally low)
Cardiac failure
Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
Fatigue (feeling of tiredness)
Hypokalaemia (low potassium)
Inflammatory marker increased
Cachexia (loss of weight)
Gastric ulcer (stomach ulcer)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Osteosynthesis

What are the common drug interactions of Palladone and Revlimid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Cardiac failure
Gastrointestinal stromal tumour (a cancer that arises from transformed cells of mesenchymal origin in gastrointestinal tract)
Appetite disorder (abnormal eating habits)
Asthma
Cough
Drug ineffective
Febrile neutropenia (fever with reduced white blood cells)
General physical health deterioration (weak health status)
Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions)
Overdose

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Acute graft versus host disease in skin (acute complication on skin following an allogeneic tissue/blood transplant)
Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
General physical health deterioration (weak health status)
Bacterial infection
Infection
Lymphoma (cancer that begins in immune system cells)
Sepsis (a severe blood infection that can lead to organ failure and death)

50-59:

Bradycardia (abnormally slow heart action)
Cardiovascular insufficiency (inadequate functioning of heart)
Arthralgia (joint pain)
Fatigue (feeling of tiredness)
Vertigo

60+:

Cardiac failure
Confusional state
Sepsis (a severe blood infection that can lead to organ failure and death)
Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
General physical health deterioration (weak health status)
Hypokalaemia (low potassium)
Inflammatory marker increased
Cachexia (loss of weight)
Fatigue (feeling of tiredness)
Gastric ulcer (stomach ulcer)

What are the existing conditions these people have? *

High Blood Pressure: 8 people, 25.00%
Osteoporosis (bones weak and more likely to break): 7 people, 21.88%
Infection: 7 people, 21.88%
Glaucoma (increased fluid pressure in the eye with vision loss): 7 people, 21.88%
Myeloma Recurrence (recurrence of cancer of the plasma cells - a kind of white blood cell): 6 people, 18.75%
Pain: 5 people, 15.62%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 12.50%
Plasmacytoma (neoplasm of plasma cells (usually in bone marrow)): 3 people, 9.38%
Febrile Neutropenia (fever with reduced white blood cells): 3 people, 9.38%

* Approximation only. Some reports may have incomplete information.

Do you take Palladone and Revlimid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously